Trainline Raises FullYear Outlook for Second Time in Fiscal 2026 Consumer Prices Rise 38 in April Exceeding Expectations and Marking Highest Inflation Since May 2023 Trainline Shares Rally as Company Raises FullYear Guidance for Second Time in Fiscal 2026 Biotech Sector in 2026 Investment Opportunities and Considerations CRISPR Therapeutics Releases First Quarter 2026 Results Key Updates on Gene Editing Pipeline Bitcoin Ethereum Continue Decline Amid 400M Liquidations Macro and Geopolitical Headwinds Persist Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting It with Bed Bath Beyond